Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months (Q44097759)
Jump to navigation
Jump to search
scientific article published in August 2002
Language | Label | Description | Also known as |
---|---|---|---|
English | Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months |
scientific article published in August 2002 |
Statements
1 reference
Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months (English)
1 reference
Nicholas J Talley
1 reference
Thomas L Venables
1 reference
Jonathan R B Green
1 reference
David Armstrong
1 reference
Kevin P J O'Kane
1 reference
Mustafa Giaffer
1 reference
Karna D Bardhan
1 reference
Rolf G S Carlsson
1 reference
Samuel Chen
1 reference
Göran S Hasselgren
1 reference
1 August 2002
1 reference
1 reference
14
1 reference
8
1 reference
857-863
1 reference
Identifiers
1 reference
1 reference